Related Experiment Video
Updated: Oct 10, 2025
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
16.9K
Transparency in public pharmaceutical sector: the key informants' perceptions from a developing country
Atefeh Esfandiari1, Vahid Yazdi-Feyzabadi2,3, Leila Zarei4
1Department of Health Policy & Management, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
BMC Health Services Research
|December 8, 2021
Summary
This study found significant transparency issues and ethical problems in Iran's public pharmaceutical sector. Solutions include evidence-based decisions and conflict of interest declarations for better pharmaceutical policy.
Area of Science:
- Health Policy
- Pharmaceutical Management
- Public Health
Background:
- Pharmaceutical policymaking is crucial for health system goals.
- Transparency in pharmaceutical policy enhances decision-making confidence.
- This study assesses transparency in Iran's public pharmaceutical sector.
Purpose of the Study:
- To evaluate transparency within Iran's public pharmaceutical sector.
- To identify general and ethical problems affecting pharmaceutical transparency.
- To propose solutions for improving pharmaceutical policy and transparency.
Main Methods:
- Qualitative study utilizing content analysis.
- Employed the World Health Organization tool for transparency assessment.
- Conducted semi-structured interviews with diverse health system stakeholders across eight key pharmaceutical functions.
Main Results:
- Identified general problems: lack of transparency, conflicts of interest, centralization, and monopoly.
- Highlighted ethical issues: illegal payments, bribery, hidden power, hoarding, and counterfeit medicines.
- Recommended solutions: evidence-based decision-making, transparent processes, conflict of interest disclosure, and skilled human resources.
Conclusions:
- Pharmaceutical policy review is essential in certain functions despite existing interventions.
- Implementing conflict of interest statements is critical for enhancing policy transparency.
- Improving transparency is key to achieving health system goals through effective pharmaceutical policy.
More Related Videos
Related Concept Videos
01:19Pharmacovigilance
1.1K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
279
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
279
01:25Drug Regulation
2.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.0K
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.7K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
16
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
16
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
22
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
22